## BX: Blackstone Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.46 indicates fundamental undervaluation. Quality metrics strong (ROE 26%, ROA 12%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (56% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($152.02)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Blackstone Inc.: How a Private Markets Engine Became the Flagship Product Wall Street Can’t Ignore**
- Source: AD HOC NEWS | 20260101T070754 | Bullish | Relevance: 100%
- Blackstone Inc. has transformed into a productized platform for alternative investments, offering scalable strategies across real estate, credit, infrastructure, and secondaries. This approach provides institutional and affluent retail investors with access to private markets, yield, diversification, and risk management through various curated products. The company's competitive edge lies in its platform scale, data-driven management, product innovation, global brand, and ecosystem effects, positioning its stock as a hybrid growth and cash-flow compounder in the alternatives space.

**2. Key facts: Blackstone's stock down 10.2% in 2025; partners with TPG on Hologic**
- Source: TradingView — Track All Markets | 20251231T200730 | Somewhat-Bearish | Relevance: 100%
- Blackstone's stock (BX) has decreased by 10.2% in 2025 due to worries about the private credit sector following recent bankruptcies. In the same year, Blackstone collaborated with TPG to acquire the women's health company Hologic, contributing to the private equity deal activity.

**3. Blackstone: Robust Dividend Growth Meets Massive Asset Accumulation (NYSE:BX)**
- Source: Seeking Alpha | 20260102T093540 | Bullish | Relevance: 100%
- Blackstone (BX) receives a buy rating due to its transformation into a global capital engine with over $1 trillion in Assets Under Management (AUM) and a durable, high-margin fee model. The company's scale in credit and insurance, combined with strategic partnerships, creates a recurring and defensible fee stream. Despite a premium valuation and potential regulatory risks, Blackstone's strong cash flow, dividend growth, and capital efficiency are expected to provide continued upside potential.

**4. The Truth About Blackstone Inc: Wall Street’s Favorite Power Player, But Should You Ride BX Now?**
- Source: AD HOC NEWS | 20260102T085159 | Somewhat-Bullish | Relevance: 100%
- This article analyzes Blackstone Inc. (BX), detailing its operations as a major alternative asset manager and its strong presence in real estate, private equity, and credit markets. It examines whether the stock, despite its high profile and consistent dividends, is a worthwhile investment given its volatility and sensitivity to market conditions. The piece concludes by advising potential investors to consider their long-term goals and risk tolerance before buying.

**5. Blackstone Inc.: How the Alt?Investment Powerhouse Became a Product in Its Own Right**
- Source: AD HOC NEWS | 20260101T024810 | Bullish | Relevance: 100%
- Blackstone Inc. has transformed into a product ecosystem, offering private market investments as scalable and accessible products for institutions and wealthy individuals. The company leverages integrated platforms, technology, and branding to package illiquid assets, positioning itself as a flagship access point to the private markets economy. This productized model, emphasizing scale, specialization, and broad access, significantly influences its valuation and stock performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $172 | $165 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 10 ($30.98M) |
| Sells | 4 ($24.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+1.9%)
- Blackrock Inc.: 6.9% (-1.1%)
- JPMORGAN CHASE & CO: 6.8% (+166.7%)
- Morgan Stanley: 4.4% (+1.8%)
- State Street Corpora: 4.2% (+1.3%)

### Key Risks

1. Volume divergence: price rising (+2.7% MRS) on declining volume (56% of avg) suggests distribution.
2. Heavy insider selling: $24M sold (4 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Momentum building: MRS_20 improving +2.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Quality metrics strong (ROE 26%, ROA 12%, margin 21%). Balance sheet: $1.6B free cash flow. Revenue growth strong at 26% YoY. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $194.9B |
| Beta | 1.76 |
| 52W Range | $115.66 - $190.09 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 24.7 |
| Current P/E | 29.9 |
| YoY Growth | 21.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 1.1% to 3.8% (+2.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.2pp (needs >4.0% for momentum thesis). MRS_5 at 2.7% confirms short-term momentum alignment. AM_20 at 3.2% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 56% of 20MA suggests lack of conviction. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.75% (CS: 85) | Neutral |
| RSI_14 | 64.4 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.066x | Above |
| vs SMA200 | 1.035x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $158.80
- **Stop Loss:** $152.02 (4.3% risk)
- **Target:** $172.36 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 212
- **Position Value:** $33,665.60
- **Portfolio %:** 33.67%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $1.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.52 | +23.9% |
| 2025Q2 | $1.10 | $1.21 | +9.8% |
| 2025Q1 | $1.06 | $1.09 | +3.1% |
| 2024Q4 | $1.47 | $1.69 | +15.2% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*